HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Ehrenfried Schindler Friedhelm F. Dapper Gunter Hempelmann Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boldt, J. Articles by Hempelmann, G. Search for Related Content PubMed PubMed Citation Articles by Boldt, J. Articles by Hempelmann, G.

Ann Thorac Surg 1994;57:1584-1589
© 1994 The Society of Thoracic Surgeons

---

Articles

Thrombomodulin in pediatric cardiac surgery

Department of Anesthesiology and Intensive Care Mediane and Department of Cardiovascular Surgery, Justus-Liebig-University Giessen, Giessen, Germany

Accepted for publication October 20, 1993.

^_* Address reprint requests to Dr Boldt, Department of Anesthesiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Klinikstrasse 29, 35392 Giessen, Germany.

In 30 consecutive children with congenital heart disease scheduled for pediatric cardiac operations, thrombomodulin, protein C, free protein S, and thrombin-antithiombin complex were measured by enzyme-linked immunosorbent assay after the induction of anesthesia (baseline value), and then before, during, and after cardiopulmonary bypass until the first postoperative day. The patients were divided prospectively into two groups: children weighing less than 10 kg (group 1; n = 15) and those weighing more than 10 kg (group 2; n = 15). At baseline, the plasma concentration of thrombomodulin was significantly higher in the children in group 1 than in those in group 2 (83.1 ± 11.0 ng/mL versus 29.2 ± 12.1 ng/mL). During cardiopulmonary bypass, the thrombomodulin level was reduced in both groups without showing any significant group differences. Five hours after cardiopulmonary bypass and on the first postoperative day, the thrombomodulin level exceeded normal values only in the children weighing less than 10 kg. In both groups, the protein C levels were already below normal at the beginning of the study. The baseline protein S concentration was higher in the smaller children (80% ± 18%) than in the larger children (66% ± 11%). It was reduced by cardiopulmonary bypass in both groups; however, postoperatively it did not return to normal in group 1 (45.1% ± 10%). Plasma levels of the thrombin-antithrombin complex were similar in both groups, with a marked increase at the end of cardiopulmonary bypass, and returned to near-normal levels by 5 hours after bypass. Other coagulation variables (the partial thromboplastin time and the antithrombin III and fibrinogen levels) were not significantly different between the two groups. Postoperative blood loss was significantly higher in the smaller children on the first postoperative day (35.3 ± 20.1 mL/kg) than in the children weighing more than 10 kg (11.8 ± 5.0 mL/kg). Five children in group 1 and 2 children in group 2 received fresh frozen plasm; in the postbypass period (p < 0.05). It is concluded that the endothelium is involved in the regulation of hemostasis by producing the natural anticoagulant thrombomodulin. This endothelium-related system was significantly more altered in the smaller children with congenital heart disease undergoing cardiac operations, than it was in the bigger children, which may have contributed to the greater bleeding tendency in these children.

This article has been cited by other articles:

				J. Jaggers and J. H. Lawson Coagulopathy and Inflammation in Neonatal Heart Surgery: Mechanisms and Strategies Ann. Thorac. Surg., June 1, 2006; 81(6): S2360 - S2366. [Full Text] [PDF]

				H. A. Hennein Inflammation After Cardiopulmonary Bypass: Therapy for the Postpump Syndrome Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 236 - 255. [Abstract] [PDF]

				J. Petaja, K. Peltola, and P. Rautiainen DISAPPEARANCE OF SYMPTOMATIC VENOUS THROMBOSIS AFTER NEONATAL CARDIAC OPERATIONS DURING ANTITHROMBIN III SUBSTITUTION J. Thorac. Cardiovasc. Surg., November 1, 1999; 118(5): 955 - 956. [Full Text] [PDF]

				G. M. So, M. R. Herbert, E. C. Dooling, F. Buonanno, B. E. Kosofsky, and D. Ebb Multifocal Embolic Strokes Following Cardiac Surgery in a Protein C-Deficient Child J Child Neurol, December 1, 1998; 13(12): 629 - 631. [PDF]

				G. D. Williams, S. L. Bratton, E. C. Riley, and C. Ramamoorthy Association between age and blood loss in children undergoing open heart operations Ann. Thorac. Surg., September 1, 1998; 66(3): 870 - 875. [Abstract] [Full Text] [PDF]

				K. Takigami, S. Sasaki, N. Shiiya, M. Kawasaki, E. Takeuchi, and K. Yasuda Evaluation of 18-hour lung preservation with oxygenated blood for optimal oxygen delivery Ann. Thorac. Surg., August 1, 1998; 66(2): 362 - 366. [Abstract] [Full Text] [PDF]

				J. Petaja, U. Lundstrom, H. Sairanen, E. Marttinen, and J. H. Griffin CENTRAL VENOUS THROMBOSIS AFTER CARDIAC OPERATIONS IN CHILDREN J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 883 - 889. [Abstract] [Full Text]

				J. Petaja, K. Peltola, H. Sairanen, M. Leijala, R. Kekomaki, E. Vahtera, and M. A. Siimes FIBRINOLYSIS, ANTITHROMBIN III, AND PROTEIN C IN NEONATES DURING CARDIAC OPERATIONS J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 665 - 671. [Abstract] [Full Text]